FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Rising Pharmaceuticals Timolol Maleate Sterile Opthalmic Solution Recall

Timolol Maleate Sterile Opthalmic Solution,USP 0

Rising Pharmaceuticals, Inc. · Saddle Brook, NJ

Risk level
Class III
Reported by FDA
Jul 1, 2020
Recall ID
D-1368-2020
Check your lot numberHow we source this data

Summary

Rising Pharmaceuticals recalled Timolol Maleate Sterile Opthalmic Solution starting Nov 15, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1368-2020 on Jul 1, 2020. Reason: Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml. Status: Terminated.

Why it was recalled

Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.

Product description

Timolol Maleate Sterile Opthalmic Solution,USP 0.25%, 5 mL, Rx Only, For Topical Application, Distributed by: Rising Pharmaceuticals, Inc. Saddle Brook, NJ 07863, Manufactured by: FDC Limited B-8, MDC Industrial Area, Waluj, Aurangabad - 431-136 Maharashtra, India, NDC 64980-513-05

Lot numbers, UPCs & expiration codes

Lot # 089A016, Exp 12/2020

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1368-2020
Classification
Class III
Status
Terminated
Recall initiated
Nov 15, 2019
FDA report date
Jul 1, 2020
Quantity
15,072 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Rising Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1368-2020, exactly as published.

Show all FDA fields
City
Saddle Brook
State
NJ
Status
Terminated
Country
United States
Event ID
85829
Address
250 Pehle Ave Ste 601
Code information
Lot # 089A016, Exp 12/2020
Postal code
07663-5832
Report date
Jul 1, 2020
Product type
Drugs
Recall number
D-1368-2020
Classification
Class III
Recalling firm
Rising Pharmaceuticals, Inc.
Product quantity
15,072 bottles
Termination date
Aug 22, 2022
Reason for recall
Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Timolol Maleate Sterile Opthalmic Solution,USP 0.25%, 5 mL, Rx Only, For Topical Application, Distributed by: Rising Pharmaceuticals, Inc. Saddle Brook, NJ 07863, Manufactured by: FDC Limited B-8, MDC Industrial Area, Waluj, Aurangabad - 431-136 Maharashtra, India, NDC 64980-513-05
Distribution pattern
U.S.A. Nationwide
Recall initiation date
Nov 15, 2019
Initial firm notification
Letter
Center classification date
Jun 29, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1368-2020, published Jul 1, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls